Bradley Wright, PharmD

FDA is requiring a class labeling change that will allow many more diabetes patients to benefit from metformin.

Got a minute? Check out this concise review of the facts about long-acting insulin formulations Toujeo and Tresiba.

Every-other-day dosing, especially of statins with longer half-lives is shown to preserve lipid-lowering benefits.

Barriers to the use of statins-the most potent medicine currently available in the fight against atherosclerotic heart disease-are both real and perceived.

Newly diagnosed hypertension in a patient whose blood pressure is 152/94 mm Hg. What agents will you consider for this patient? Beta-blockers? Think again.

Some say chlorthalidone is superior to hydrochlorothiazide and should be used as first-line therapy in hypertension. A compelling case can be made for resurrecting this venerable drug.